Abbott Laboratories (ABT) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.69% |
| Dec 31, 2025 | 97.47% |
| Sep 30, 2025 | 4.04% |
| Jun 30, 2025 | 4.08% |
| Mar 31, 2025 | 4.05% |
| Dec 31, 2024 | 73.12% |
| Sep 30, 2024 | 1.64% |
| Jun 30, 2024 | 1.31% |
| Mar 31, 2024 | 1.40% |
| Dec 31, 2023 | 1.74% |
| Sep 30, 2023 | 0.13% |
| Jun 30, 2023 | 1.40% |
| Mar 31, 2023 | 0.80% |
| Dec 31, 2022 | -48.06% |
| Sep 30, 2022 | 0.15% |
| Jun 30, 2022 | 0.84% |
| Mar 31, 2022 | 0.87% |
| Dec 31, 2021 | -32.72% |
| Sep 30, 2021 | 13.32% |
| Jun 30, 2021 | 12.96% |
| Mar 31, 2021 | 12.92% |
| Dec 31, 2020 | -41.25% |
| Sep 30, 2020 | 10.60% |
| Jun 30, 2020 | 9.28% |
| Mar 31, 2020 | 9.15% |
| Dec 31, 2019 | -33.81% |
| Sep 30, 2019 | 10.02% |
| Jun 30, 2019 | 10.53% |
| Mar 31, 2019 | 10.17% |
| Dec 31, 2018 | 9.36% |
| Sep 30, 2018 | 10.17% |
| Jun 30, 2018 | 9.78% |
| Mar 31, 2018 | 10.68% |
| Dec 31, 2017 | 2.55% |
| Sep 30, 2017 | 2.69% |
| Jun 30, 2017 | 2.84% |
| Mar 31, 2017 | 2.58% |
| Dec 31, 2016 | -2.66% |
| Sep 30, 2016 | -7.91% |
| Jun 30, 2016 | -8.47% |
| Mar 31, 2016 | -8.46% |
| Dec 31, 2015 | -7.40% |
| Sep 30, 2015 | -6.17% |
| Jun 30, 2015 | -3.74% |
| Dec 31, 2014 | -4.76% |
| Sep 30, 2014 | -3.13% |
| Jun 30, 2014 | -2.73% |